Yong Serk Park
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 8
-
- RNA Interference and Gene Delivery 21
- Advanced biosensing and bioanalysis techniques 14
- Angiogenesis and VEGF in Cancer 4
- Glycosylation and Glycoproteins Research 3
- Pharmaceutical Science top 10%
- Orthopedics and Sports Medicine top 10%
-
- Nanoplatforms for cancer theranostics 4
-
- Virus-based gene therapy research 7
-
- Knee injuries and reconstruction techniques 3
- Co-authors
- Leaf HuangIn Ho SongHwa Yeon JeongTae Sup LeeMoon Jung ChoiMin Woo KimSeong Jae KangChan Im
- Journals
- International Journal of Molecular Sciences (4 papers)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (3 papers)Cancer Gene Therapy (2 papers)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Yong Serk Park
38 papers receiving 877 citations
Peers
Comparison fields: 5 of 84
- Biomaterials 235
- Molecular Biology 555
- Pharmaceutical Science 33
- Orthopedics and Sports Medicine 43
- Biomedical Engineering 202
Countries citing papers authored by Yong Serk Park
This map shows the geographic impact of Yong Serk Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Serk Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Serk Park more than expected).
Fields of papers citing papers by Yong Serk Park
This network shows the impact of papers produced by Yong Serk Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Serk Park. The network helps show where Yong Serk Park may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yong Serk Park, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 9 | |
| 5 | 2020 | 25 | |
| 6 | 2019 | 98 | |
| 7 | 2018 | 14 | |
| 8 | 2018 | 43 | |
| 9 | 2017 | 65 | |
| 10 | 2016 | 10 | |
| 11 | 2014 | 118 | |
| 12 | 2010 | 25 | |
| 13 | 2010 | 23 | |
| 14 | 2010 | 35 | |
| 15 | 2006 | 53 | |
| 16 | 2004 | 18 | |
| 17 | 2002 | 7 | |
| 18 | 1992 | 14 | |
| 19 | 1992 | 39 | |
| 20 | 1992 | 9 |
About Yong Serk Park
Yong Serk Park is a scholar working on Biomaterials, Molecular Biology and Immunology and Allergy, having authored 38 papers that have together received 903 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (21 papers), Advanced biosensing and bioanalysis techniques (14 papers), Nanoparticle-Based Drug Delivery (8 papers), Virus-based gene therapy research (7 papers), Angiogenesis and VEGF in Cancer (4 papers), Nanoplatforms for cancer theranostics (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Knee injuries and reconstruction techniques (3 papers). The work is most often cited by research in Biomaterials (235 citations), Molecular Biology (555 citations) and Pharmaceutical Science (33 citations). Yong Serk Park has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Leaf Huang, In Ho Song, Hwa Yeon Jeong, Tae Sup Lee, Moon Jung Choi, Min Woo Kim, Seong Jae Kang, Chan Im, Dong‐Eun Kim and Keun‐Sik Kim. Their work appears in journals such as International Journal of Molecular Sciences, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Cancer Gene Therapy, Biochimica et Biophysica Acta (BBA) - Biomembranes and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.